MX2010013931A - Diagnosis de cancer basada en niveles de anticuerpos contra globo h y sus fragmentos. - Google Patents

Diagnosis de cancer basada en niveles de anticuerpos contra globo h y sus fragmentos.

Info

Publication number
MX2010013931A
MX2010013931A MX2010013931A MX2010013931A MX2010013931A MX 2010013931 A MX2010013931 A MX 2010013931A MX 2010013931 A MX2010013931 A MX 2010013931A MX 2010013931 A MX2010013931 A MX 2010013931A MX 2010013931 A MX2010013931 A MX 2010013931A
Authority
MX
Mexico
Prior art keywords
cancer
sample
globe
antibodies
globo
Prior art date
Application number
MX2010013931A
Other languages
English (en)
Spanish (es)
Inventor
Chi-Huey Wong
Chung-Yi Wu
Cheng-Chi Wang
Alice L Yu
Original Assignee
Academia Sinica
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Academia Sinica filed Critical Academia Sinica
Publication of MX2010013931A publication Critical patent/MX2010013931A/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • G01N33/57585—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites involving compounds identifiable in body fluids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57515—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the breast

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
MX2010013931A 2008-06-16 2009-06-16 Diagnosis de cancer basada en niveles de anticuerpos contra globo h y sus fragmentos. MX2010013931A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6197408P 2008-06-16 2008-06-16
PCT/US2009/047532 WO2010008736A2 (en) 2008-06-16 2009-06-16 Cancer diagnosis based on levels of antibodies against globo h and its fragments

Publications (1)

Publication Number Publication Date
MX2010013931A true MX2010013931A (es) 2011-06-01

Family

ID=41431641

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010013931A MX2010013931A (es) 2008-06-16 2009-06-16 Diagnosis de cancer basada en niveles de anticuerpos contra globo h y sus fragmentos.

Country Status (11)

Country Link
US (1) US8158367B2 (enExample)
EP (1) EP2307887B1 (enExample)
JP (1) JP5216139B2 (enExample)
KR (1) KR101324109B1 (enExample)
CN (1) CN102066940B (enExample)
AU (1) AU2009271411B2 (enExample)
CA (1) CA2728574C (enExample)
ES (1) ES2477549T3 (enExample)
MX (1) MX2010013931A (enExample)
NZ (1) NZ590064A (enExample)
WO (1) WO2010008736A2 (enExample)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7960139B2 (en) 2007-03-23 2011-06-14 Academia Sinica Alkynyl sugar analogs for the labeling and visualization of glycoconjugates in cells
JP5986745B2 (ja) 2008-07-15 2016-09-06 アカデミア シニカＡｃａｄｅｍｉａ Ｓｉｎｉｃａ Ｐｔｆｅ様のアルミニウム・コート・ガラススライド上のグリカンアレイおよび関連する方法
US10087236B2 (en) 2009-12-02 2018-10-02 Academia Sinica Methods for modifying human antibodies by glycan engineering
US11377485B2 (en) 2009-12-02 2022-07-05 Academia Sinica Methods for modifying human antibodies by glycan engineering
US8957107B2 (en) 2009-12-15 2015-02-17 The Hospital For Sick Children Method of treating scars and β-catenin-mediated disorders using Nefopam compounds
WO2011130332A1 (en) 2010-04-12 2011-10-20 Academia Sinica Glycan arrays for high throughput screening of viruses
US10132817B2 (en) 2011-07-12 2018-11-20 Rowan University Diagnostic biomarker profiles for the detection and diagnosis of alzheimer's disease
US10130714B2 (en) 2012-04-14 2018-11-20 Academia Sinica Enhanced anti-influenza agents conjugated with anti-inflammatory activity
WO2014018903A1 (en) * 2012-07-27 2014-01-30 Rowan University Autoantibody profiles in early detection and diagnosis of cancer
WO2014031498A1 (en) 2012-08-18 2014-02-27 Academia Sinica Cell-permeable probes for identification and imaging of sialidases
US10086054B2 (en) 2013-06-26 2018-10-02 Academia Sinica RM2 antigens and use thereof
WO2014210564A1 (en) 2013-06-27 2014-12-31 Academia Sinica Glycan conjugates and use thereof
JP6486368B2 (ja) 2013-09-06 2019-03-20 アカデミア シニカＡｃａｄｅｍｉａ Ｓｉｎｉｃａ 改変されたグリコシル基を含む糖脂質を用いたヒトｉＮＫＴ細胞の活性化
CN104698183A (zh) * 2013-12-04 2015-06-10 苏州中赢医疗科技有限公司 一种肝癌肿瘤标志物、其抗体及应用
US10150818B2 (en) 2014-01-16 2018-12-11 Academia Sinica Compositions and methods for treatment and detection of cancers
TW201620939A (zh) 2014-01-16 2016-06-16 中央研究院 治療及檢測癌症之組合物及方法
MX2016012124A (es) 2014-03-19 2017-04-06 Mackay Medical Found The Presbyterian Church In Taiwan Mackay Memorial Hospital Anticuerpos contra glicopeptidos inmunogenicos, composicion que los comprende y usos de estos.
EP3129767B1 (en) 2014-03-27 2021-09-01 Academia Sinica Reactive labelling compounds and uses thereof
CA3104268A1 (en) 2014-04-10 2015-10-15 Obi Pharma Inc. Antibodies, pharmaceutical compositions and uses thereof
KR20170003720A (ko) 2014-05-27 2017-01-09 아카데미아 시니카 항-ｃｄ20 글리코항체 및 이의 용도
US10118969B2 (en) 2014-05-27 2018-11-06 Academia Sinica Compositions and methods relating to universal glycoforms for enhanced antibody efficacy
AU2015267045B2 (en) 2014-05-27 2021-02-25 Academia Sinica Anti-HER2 glycoantibodies and uses thereof
DK3149045T3 (da) 2014-05-27 2023-03-06 Academia Sinica Sammensætninger og fremgangsmåder vedrørende universelle glycoformer til forbedret antistofeffekt
JP7063538B2 (ja) 2014-05-28 2022-05-09 アカデミア シニカ 抗ＴＮＦα糖操作抗体群およびその使用
EP3191500A4 (en) 2014-09-08 2018-04-11 Academia Sinica HUMAN iNKT CELL ACTIVATION USING GLYCOLIPIDS
US10495645B2 (en) 2015-01-16 2019-12-03 Academia Sinica Cancer markers and methods of use thereof
US9975965B2 (en) 2015-01-16 2018-05-22 Academia Sinica Compositions and methods for treatment and detection of cancers
KR102630294B1 (ko) 2015-01-24 2024-01-26 아카데미아 시니카 암 마커 및 이를 사용하는 방법
US10342858B2 (en) 2015-01-24 2019-07-09 Academia Sinica Glycan conjugates and methods of use thereof
TWI717333B (zh) 2015-01-30 2021-02-01 中央研究院 增進抗體功效之通用糖型組合物及方法
JP6822957B2 (ja) * 2015-07-30 2021-01-27 京セラ株式会社 測定方法、および測定装置
JP2018532990A (ja) * 2015-09-04 2018-11-08 オービーアイ ファーマ，インコーポレイテッド グリカンアレイおよび使用の方法
AU2017231749A1 (en) 2016-03-08 2018-09-20 Academia Sinica Methods for modular synthesis of N-glycans and arrays thereof
EP3491026A4 (en) * 2016-07-29 2020-07-29 OBI Pharma, Inc. HUMAN ANTIBODIES, PHARMACEUTICAL COMPOSITIONS AND PROCESSES
AU2017316663B2 (en) 2016-08-22 2024-02-22 CHO Pharma Inc. Antibodies, binding fragments, and methods of use

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0996455B1 (en) 1997-04-16 2009-12-16 Sloan-Kettering Institute For Cancer Research Alpha-o-linked glycoconjugates with clustered (2,6)-st epitopes, methods of preparation and uses thereof
CN1235831A (zh) * 1999-03-02 1999-11-24 第一军医大学珠江医院 含红细胞糖苷脂的药物组合物及其应用
US20020006629A1 (en) * 2000-02-29 2002-01-17 Danishefsky Samuel J. Affinity matrix bearing tumor-associated carbohydrate-or glycopeptide-based antigens and uses thereof
WO2006068758A2 (en) 2004-11-19 2006-06-29 The Scripps Research Institute Detection, prevention and treatment of breast cancer
US20060269979A1 (en) * 2005-04-26 2006-11-30 Dwek Raymond A High throughput glycan analysis for diagnosing and monitoring rheumatoid arthritis and other autoimmune diseases
US20090162405A1 (en) * 2006-12-14 2009-06-25 Yong Qian Proteinase-engineered cancer vaccine induces immune responses to prevent cancer and to systemically kill cancer cells
JP2011524375A (ja) * 2008-06-16 2011-09-01 アカデミア シニカ ＧｌｏｂｏＨおよびＳＳＥＡ３に特異的な免疫反応を誘起する組成物および癌治療におけるその使用

Also Published As

Publication number Publication date
AU2009271411A1 (en) 2010-01-21
AU2009271411B2 (en) 2013-02-07
EP2307887A2 (en) 2011-04-13
JP5216139B2 (ja) 2013-06-19
US8158367B2 (en) 2012-04-17
KR20110033919A (ko) 2011-04-01
NZ590064A (en) 2012-05-25
CN102066940A (zh) 2011-05-18
WO2010008736A2 (en) 2010-01-21
EP2307887A4 (en) 2011-09-21
EP2307887B1 (en) 2014-05-07
CA2728574A1 (en) 2010-01-21
CA2728574C (en) 2020-10-20
WO2010008736A3 (en) 2010-03-11
HK1153273A1 (en) 2012-03-23
ES2477549T3 (es) 2014-07-17
KR101324109B1 (ko) 2013-10-31
JP2011524537A (ja) 2011-09-01
US20090317837A1 (en) 2009-12-24
CN102066940B (zh) 2015-05-13

Similar Documents

Publication Publication Date Title
AU2009271411B2 (en) Cancer diagnosis based on levels of antibodies against Globo H and its fragments
Wang et al. Glycan microarray of Globo H and related structures for quantitative analysis of breast cancer
Yang et al. Improvement of protein immobilization for the elaboration of tumor-associated antigen microarrays: application to the sensitive and specific detection of tumor markers from breast cancer sera
CN1362970A (zh) 对雌激素受激亮氨酸氨基太酶的单克隆抗体
US20130189707A1 (en) Method of determination of autoantibody level by means of enzyme immunoassay
Wang et al. Anti‐oligomannose antibodies as potential serum biomarkers of aggressive prostate cancer
CN100384876C (zh) 抗脱唾液酸α1－酸性糖蛋白的单克隆抗体、用于免疫色谱以检测脱唾液酸α1－酸性糖蛋白的诊断条和使用其诊断肝病的方法
CN109239326A (zh) 基于磁颗粒纳米酶的微流控免疫芯片分析方法及应用
Diós et al. Gamma-gliadin specific celiac disease antibodies recognize p31-43 and p57-68 alpha gliadin peptides in deamidation related manner as a result of cross-reaction
CN106279403B (zh) 一种检测天然肺癌相关抗体的组合物、试剂盒和方法
KR102031845B1 (ko) 신규한 면역글로불린 e의 에피토프, 그와 결합하는 항체 및 상기 항체를 포함하는 시료 중 면역글로불린 e를 분석하기 위한 키트
WO1996028569A1 (en) Monoclonal antibody and antigen relating to human pulmonary adenocarcinoma and immunoassay method with the use of the same
CN110412274B (zh) C6orf106自身抗体检测试剂在制备肺癌筛查试剂盒中的用途
WO2014147101A1 (en) Specific detection of rat antibodies in mouse serum
JP4476801B2 (ja) 新生物の検出方法
CN101759780B (zh) 可溶性肝抗原t细胞抗原表位及由其制备的检测试剂盒
US7718780B2 (en) Preparation of monoclonal antibody to N-myc downstream regulated gene 2 and determination of NDRG2 using protein chip
HK1153273B (en) Cancer diagnosis based on levels of antibodies against globo h and its fragments
Enayati et al. Development of enzyme-linked immunosorbent assay (ELISA) based on covalent immobilization of antibody on plate for measurement of digoxin
CN109900901A (zh) 改进的诊断真菌感染的方法
CN111217910A (zh) 单克隆抗体对及其在检测髓过氧化物酶蛋白中的应用
Cui et al. A Rapid and Highly Sensitive Chemiluminescent Method to Quantify HPV16E7 Antibody Based on Immunomagnetic Separation Methods.
KR20120021518A (ko) 간암 진단용 조성물 및 진단방법
JP3995316B2 (ja) ホルモンレセプターに対する自己抗体の測定による癌の検出方法
CN108152495A (zh) 一种检测酪氨酸的胶体金试纸

Legal Events

Date Code Title Description
FG Grant or registration